October 26, 2022
Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
May 21, 2014
Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells – cancer avatars – to identify drugs most likely to kill cancer cells isolated from patients’ brain tumors.
January 23, 2014
…survival is also activated in surrounding blood vessels, enabling cancer cells to spread into the bloodstream.
October 28, 2014
…Award from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to support four predoctoral and six postdoctoral scholars in the campus’s cancer training program. First awarded in 1984, the grant is the single longest-running NCI training grant at UC San Diego. The 2014 grant renewal…
January 20, 2017
…use of stem cell-derived natural killer (NK) cells to target ovarian cancer and other malignancies.
September 5, 2017
…of Medicine in St. Louis report the virus specifically targets and kills brain cancer stem cells.
October 6, 2020
J. Silvio Gutkind, PhD, has been named chair of the Department of Pharmacology at UC San Diego School of Medicine.
May 8, 2015
Therapies that specifically target mutations in a person’s cancer have been much-heralded in recent years, yet cancer cells often find a way around them. To address this, researchers at University of California, San Diego School of Medicine and Moores Cancer Center identified a promising combinatorial approach to treating glioblastomas, the…
November 18, 2011
…Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant brain tumor.
October 4, 2016
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.
